Sichenzia Ross Ference LLP Represents H.C. Wainwright in $7.5 Million At-The-Market Offering of Ekso Bionics

Press Release – New York, NY – October 15, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC as sales agent in a $7.5 million At-The-Market Offering (“ATM”) of Ekso Bionics Holdings, Inc. (NASDAQ: “EKSO”) common stock.

The shares were registered on EKSO’s registration statement on Form S-3 (File No. 333-239203), which was declared effective by the SEC on June 26, 2020, and prospectus supplement relating to the ATM filed with the SEC on October 9, 2020.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio, Avital Perlman, Barrett DiPaolo and associate Jacob Tabman.